Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-28T12:38:57.344Z Has data issue: false hasContentIssue false
  • English
  • Français

2870 – Diabete and Schizophrenia: Retrospective Study

Published online by Cambridge University Press:  15 April 2020

R. Ennaoui ,
R. Jomli ,
Y. Zgueb ,
A. Ouertani  and
F. Nacef
R. Ennaoui
Affiliation:
Department of Psychiatry, Razi Hospital, Tunis, Tunisia
R. Jomli
Affiliation:
Department of Psychiatry, Razi Hospital, Tunis, Tunisia
Y. Zgueb
Affiliation:
Department of Psychiatry, Razi Hospital, Tunis, Tunisia
A. Ouertani
Affiliation:
Department of Psychiatry, Razi Hospital, Tunis, Tunisia
F. Nacef
Affiliation:
Department of Psychiatry, Razi Hospital, Tunis, Tunisia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

Type II diabetes is more common in patients with schizophrenia than in the general population. Although disorders of glucose metabolism have been described in patients with schizophrenia before the introduction of atypical antipsychotics, a diabetogenic effect of these has been implicated.

Objectives:

The aims of our study were to:

  1. - assess the prevalence of diabetes in a population of patients with schizophrenia.

  2. - determine the relationship between diabetes, atypical antipsychotics and schizophrenia.

Patients and methods:

This is a retrospective study of 60 patients with schizophrenia. Data collection was done based on patient records.

Results:

The majority of patients were male with a sex ratio of 2. The average age of our patients was 38 years. 40% of patients (25) had diabetes. 33% of patients were put under an atypical anti psychotic. The diagnosis of diabetes succeeded that of schizophrenia in 40% of cases.

Conclusion:

Our results indicate that patients with schizophrenia are more likely to develop type II diabetes. We caution clinicians to consider the risk and be vigilant about this development.

Type
Abstract
Information
European Psychiatry , Volume 28 , Issue S1: Abstracts of the 21th European Congress of Psychiatry , 2013 , 28-E1736
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.